The DOI matches its Crossref record; 176 of the 176 references it cites were found in a registry or an index.
The Future of Pharmaceutical Manufacturing Sciences
Open accessAbstract
The entire pharmaceutical sector is in an urgent need of both innovative technological solutions and fundamental scientific work, enabling the production of highly engineered drug products. Commercial-scale manufacturing of complex drug delivery systems (DDSs) using the existing technologies is challenging. This review covers important elements of manufacturing sciences, beginning with risk management strategies and design of experiments (DoE) techniques. Experimental techniques should, where possible, be supported by computational approaches. With that regard, state-of-art mechanistic process modeling techniques are described in detail. Implementation of materials science tools paves the way to molecular-based processing of future DDSs. A snapshot of some of the existing tools is presented. Additionally, general engineering principles are discussed covering process measurement and process control solutions. Last part of the review addresses future manufacturing solutions, covering continuous processing and, specifically, hot-melt processing and printing-based technologies. Finally, challenges related to implementing these technologies as a part of future health care systems are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
LATTICE BOLTZMANN METHOD FOR FLUID FLOWS
Chen, S., & Doolen, G. D. (1998) · Annual Review of Fluid Mechanics · doi:10.1146/annurev.fluid.30.1.329 · Cited by 7,314
A New Initiative on Precision Medicine
Collins, F. S., & Varmus, H. (2015) · New England Journal of Medicine · doi:10.1056/nejmp1500523 · Cited by 5,202
On the quantitative definition of risk
Kaplan, S., & Garrick, B. J. (1981) · Risk Analysis · doi:10.1111/j.1539-6924.1981.tb01350.x · Cited by 3,103
Multiphase Flows with Droplets and Particles
Crowe, C. T., Schwarzkopf, J. D., Sommerfeld, M., & Tsuji, Y. (2011) · doi:10.1201/b11103 · Cited by 3,076
Lun, C. K. K., Savage, S. B., Jeffrey, D. J., & Chepurniy, N. (1984) · Journal of Fluid Mechanics · doi:10.1017/s0022112084000586 · Cited by 3,067
Review of the most common pre-processing techniques for near-infrared spectra
Rinnan, Å., Berg, F. V. D., & Engelsen, S. B. (2009) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2009.07.007 · Cited by 3,057
PARAFAC. Tutorial and applications
Bro, R. (1997) · Chemometrics and Intelligent Laboratory Systems · doi:10.1016/s0169-7439(97)00032-4 · Cited by 2,814
Ladd, A. J. C. (1994) · Journal of Fluid Mechanics · doi:10.1017/s0022112094001771 · Cited by 2,461
A front-tracking method for viscous, incompressible, multi-fluid flows
Unverdi, S. O., & Tryggvason, G. (1992) · Journal of Computational Physics · doi:10.1016/0021-9991(92)90307-k · Cited by 2,387
Fluid Mechanical Description of Fluidized Beds. Equations of Motion
Anderson, T. B., & Jackson, R. (1967) · Industrial & Engineering Chemistry Fundamentals · doi:10.1021/i160024a007 · Cited by 2,066
Cited by
Artificial intelligence in drug discovery and development
Paul, D., Sanap, G., Shenoy, S., Kalyane, D., Kalia, K., & Tekade, R. K. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2020.10.010 · Cited by 1,695
Tan, D., Loots, L., & Friščić, T. (2016) · Chemical Communications · doi:10.1039/c6cc02015a · Cited by 411
Deep learning in drug discovery: an integrative review and future challenges
Askr, H., Elgeldawi, E., Aboul Ella, H., Elshaier, Y. A. M. M., Gomaa, M. M., & Hassanien, A. E. (2023) · Artificial Intelligence Review · doi:10.1007/s10462-022-10306-1 · Cited by 390
Boyd, B. J., Bergström, C. A. S., Vinarov, Z., Kuentz, M., Brouwers, J., Augustijns, P., Brandl, M., Bernkop-Schnürch, A., Shrestha, N., Préat, V., et al. (2019) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2019.104967 · Cited by 367
Artificial Intelligence and Machine Learning Technology Driven Modern Drug Discovery and Development
Sarkar, C., Das, B., Rawat, V. S., Wahlang, J. B., Nongpiur, A., Tiewsoh, I., Lyngdoh, N. M., Das, D., Bidarolli, M., & Sony, H. T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032026 · Cited by 347
Fahim, Y. A., Hasani, I. W., Kabba, S., & Ragab, W. M. (2025) · European Journal of Medical Research · doi:10.1186/s40001-025-03196-w · Cited by 329
Sahlgren, C., Meinander, A., Zhang, H., Cheng, F., Preis, M., Xu, C., Salminen, T. A., Toivola, D., Abankwa, D., Rosling, A., et al. (2017) · Advanced Healthcare Materials · doi:10.1002/adhm.201700258 · Cited by 315
Digital Twins in Pharmaceutical and Biopharmaceutical Manufacturing: A Literature Review
Chen, Y., Yang, O., Sampat, C., Bhalode, P., Ramachandran, R., & Ierapetritou, M. (2020) · Processes · doi:10.3390/pr8091088 · Cited by 278
Grangeia, H. B., Silva, C., Simões, S. P., & Reis, M. S. (2020) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2019.12.007 · Cited by 257
Facilitating the translation of nanomedicines to a clinical product: challenges and opportunities
Agrahari, V., & Agrahari, V. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.01.047 · Cited by 253
Therapeutic RNA-silencing oligonucleotides in metabolic diseases
Goga, A., & Stoffel, M. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00407-5 · Cited by 58
Tahara, K. (2020) · Advanced Powder Technology · doi:10.1016/j.apt.2019.10.031 · Cited by 31
Metadata
- Authors
- Rantanen, J., & Khinast, J.
- Venue
- Journal of Pharmaceutical Sciences
- Publisher
- Elsevier BV
- Published
- 2015-11
- Volume
- 104
- Issue
- 11
- Pages
- 3612-3638
- ISSN
- 0022-3549 (ISSN-L)
- OpenAlex
- W1786404767
- Cited by
- 442
- References
- 176
- FWCI
- 32.60
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.